City Latest Deals

life sciences

Why LivaNova's merger was 2015's most complex life sciences deal

25-Nov-2015 | By Rachel Moloney

Pfizer’s $160bn merger with Allergan may well be the largest healthcare transaction in history, but at least the in-house team didn’t have to contend with a merger, injunction attempt, simultaneous de-listing and new listing all in one year.

pills drugs pharmaceutical pharmaceuticals pharma medicine

US and Irish firms line up on Pfizer and Allergan's $160bn merger

23-Nov-2015 | By Rachel Moloney

A host of US and Irish firms are taking the lead on Pfizer’s $160bn merger with pharmaceutical rival Allergan.


Shearman and Slaughters win roles on £3.5bn Liberty Global and Cable & Wireless deal

17-Nov-2015 | By Rachel Moloney

Shearman & Sterling and Slaughter and May have bagged the top M&A roles on the £3.5bn acquisition of Cable & Wireless Communications (CWC) by cable company Liberty Global. 


The real estate blog: Howes Percival grows in Cambridge

17-Nov-2015 | By Jonathon Manning

At the start of the month Howes Percival boosted its Cambridge office through the hire of a four strong team of real estate partners from Taylor Vinters.


Hogan Lovells joins magic circle trio in £13bn Northern Rock asset sale

13-Nov-2015 | By Rachel Moloney

Allen & Overy (A&O), Hogan Lovells, Linklaters and Slaughter and May have won top roles on the record-breaking £13bn asset portfolio sale by the UK Government to Cerberus Capital Management.  

More from City Latest Deals